Menu Back toLS12: How should We Collaborate Together to Enhance Model-Informed Drug Development?
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
18th DIA Japan Annual Meeting 2021
All prices are exclusive of 10% Japanese consumption tax
LS12: How should We Collaborate Together to Enhance Model-Informed Drug Development?
Atsushi Tsukamoto, PhD, MSc
- Vice President, Development Regulaotry Affairs
- Daiichi Sankyo Company, Limited, Japan
- Director, Clinical Pharmacology Strategy
- Bristol Myers Squibb, Japan
Norisuke Kawai, PhD
- Senior Director, Biometrics & Data Management
- Pfizer R&D Japan G.K., Japan
- Office of Advanced Evaluation with Electronic Data
- Pharmaceuticals and Medical Devices Agency, Japan